Cancer cells can repurpose a fundamental bone development program to escape therapy in a dormant state. This finding offers a way to detect cancer dormancy and assess recurrence risk using routine bone scans. See related article by Sreekumar et al., p. 781.
Gonçalves et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: